Developing innovative Artificial Pancreas Technology.
Dedicated to empowering insulin-dependent patients and their doctors with innovative and patient-centric decision support technology. The company was established in 2014 as a spin-off the DREAM International Consortium, in order to commercialize the artificial pancreas technology behind Glucositter.
